GPT Healthcare Share Price

GPT Healthcare company GPT Healthcare announced Q4FY26 & FY26 results Financial Highlights: Total Income: Total Income for Q4FY26 stood at Rs 12,800.02 lakh, reflecting a QoQ increase of 5.28% compared to Rs 12,158.02 lakh in Q3FY26, and a robust YoY growth of 24.30% from Rs 10,297.51 lakh in Q4FY25. For FY26, the Total Income was Rs 47,849.82 lakh, marking a YoY increase of 15.14% compared to Rs 41,558.57 lakh in FY25. Revenue from Operations: Revenue from operations in Q4FY26 reached Rs 12,637.18 lakh, up 5.17% QoQ from Rs 12,015.86 lakh in Q3FY26, and up 24.62% YoY from Rs 10,140.22 lakh in Q4FY25. For FY26, it was Rs 47,254.70 lakh against Rs 40,709.14 lakh in FY25 (a YoY increase of 16.08%). Profit Before Tax (PBT): PBT for Q4FY26 stood at Rs 1,586.48 lakh, demonstrating a QoQ growth of 24.35% from Rs 1,275.77 lakh in Q3FY26, but a marginal YoY decline of 3.08% from Rs 1,636.89 lakh in Q4FY25. For FY26, PBT was Rs 5,480.55 lakh, declining by 20.97% YoY compared to Rs 6,934.56 lakh in FY25. Net Profit After Tax (PAT): In Q4FY26, PAT was Rs 1,456.60 lakh, reflecting a significant QoQ growth of 55.48% from Rs 936.83 lakh in Q3FY26, and an increase of 13.00% YoY from Rs 1,289.00 lakh in Q4FY25. For the full year FY26, PAT stood at Rs 4,222.05 lakh, down 15.43% YoY compared to Rs 4,992.17 lakh in FY25. Business Highlights: Segment-wise Performance: The company operates in one single reportable business segment and geographical segment, i.e., healthcare service in India. Dividend Announcement: The Board of Directors proposed a final dividend of 15%, i.e., Rs 1.50 per Equity share. With an interim dividend of 10% (Rs 1 per Equity share) already paid, the total dividend for FY26 amounts to Rs 2.50 per Equity share (face value of Rs 10 per share). Labour Codes Impact: Following the notification of the 'New Labour Codes' by the Government of India, the company undertook an actuarial valuation for the year ended March 31, 2026, and recorded an incremental expense as a past service cost. The impact was deemed not material to the financial results. Om Tantia, GPT Healthcare Chairman, said: GPT Healthcare delivered another quarter of strong and consistent performance, underpinned by disciplined execution, improving operating metrics, and broad-based growth across both mature hospitals and newer facilities. Network occupancy improved during the quarter, supported by higher patient volumes, enhanced throughput, and a stronger specialty mix, while ARPOB recorded year-on-year growth, with ARPOB for FY26 at Rs 39,243, aligned with our strategy of serving the aspirational middle- to high-income population while maintaining affordability. The payer mix remained predominantly cash and insurance, reflecting revenue quality and financial resilience. We continued to strengthen our clinical and technological leadership, completing over 800+ robotic surgeries at ILS Salt Lake, reinforcing our position in advanced minimally invasive care, and commissioning the CTVS (Cardiothoracic and Vascular Surgery) in ILS-Dum Dum, ensuring complete cardiac care being provided under one roof. Result PDF

• Trendlyne
• 1 week 3 days ago

Conference Call with GPT Healthcare Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

• Trendlyne
• 3 months 4 weeks ago

Healthcare Facilities company GPT Healthcare announced Q3FY26 results Revenue: Rs 121.6 crore against Rs 104.1 crore during Q3FY25, change 17%. EBITDA: Rs 22.2 crore against Rs 23.1 crore during Q3FY25, change -4%. EBITDA Margin: 18.2% for Q3FY26. PAT: Rs 9.4 crore against Rs 12.1 crore during Q3FY25, change -22%. PAT Margin: 7.71% for Q3FY26. Om Tantia, Chairman, GPT Healthcare, said: GPT Healthcare delivered another quarter of strong and consistent performance, underpinned by disciplined execution, improving operating metrics, and broad-based growth across both mature hospitals and newer facilities. Network occupancy improved during the quarter, supported by higher patient volumes, enhanced throughput, and a stronger specialty mix, while ARPOB recorded YoY growth, with ARPOB for 9M’FY26 at Rs 38,797, aligned with our strategy of serving the aspirational middle- to high-income population while maintaining affordability. The payer mix remained predominantly cash and insurance, reflecting revenue quality and financial resilience. We continued to strengthen our clinical and technological leadership, completing over 750+ robotic surgeries at ILS Salt Lake, reinforcing our position in advanced minimally invasive care, and commissioning the CTVS (Cardiothoracic and Vascular Surgery) in ILS-Dum Dum, ensuring complete cardiac care being provided under one roof. Result PDF

• Trendlyne
• 3 months 4 weeks ago